Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 127, Issue 3, Pages 772-779Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI85113
Keywords
-
Categories
Funding
- European Commission FP7 program [HEALTH-F2-2013-602114]
- Rosetrees Trust [M536] Funding Source: researchfish
Ask authors/readers for more resources
Regulatory B cells (Bregs) modulate immune responses predominantly, although not exclusively, via the release of IL-10. The importance of human Bregs in the maintenance of immune homeostasis comes from a variety of immune-related pathologies, such as autoimmune diseases, cancers, and chronic infections that are often associated with abnormalities in Breg numbers or function. A continuous effort toward understanding Breg biology in healthy individuals will provide new opportunities to develop Breg immunotherapy that could prove beneficial in treating various immune-mediated pathologies. In this Review, we discuss findings regarding human Bregs, including their mechanisms of suppression and role in different disease settings. We also propose several therapeutic strategies targeting Bregs for better management of immune disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available